Compound Detail
CHEMBL571987
LERSIVIRINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL571987 |
| Name | LERSIVIRINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | MCPUZZJBAHRIPO-UHFFFAOYSA-N |
5
Targets
16
Activities
4
Assay Types
15
PK Parameters
20
Publications
4
Known Names
1
Indications
1
Mechanisms
Molecular Properties
310.4
MW (Da)
2.54
ALogP
6
HBA
1
HBD
94.9
PSA (Ų)
0.88
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase inhibitor | INHIBITOR | Human immunodeficiency virus type 1 reverse transcriptase | ✓ | ✓ |
Indications
HIV Infections
Activity Summary
IC50 8 meas. best 8.4
EC50 6 meas. best 10.3
Kd 1 meas. best 6.21
Ki 1 meas. best 6.93
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 10.3 | 8.934 | 0.1 | 5 |
| Human immunodeficiency virus CHEMBL613758 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | IC50 | 6.93 | 6.8 | 118.0 | 2 |
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | Ki | 6.93 | 6.93 | 117.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.92 | 6.4533 | 119.0 | 3 |
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | Kd | 6.21 | 6.21 | 624.0 | 1 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 4.26 | 4.26 | 54670.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 10967.32 | ng.hr.mL-1 | Homo sapiens |
| AUC | 11167.68 | ng.hr.mL-1 | Homo sapiens |
| CL | 25.9 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 25.9 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 4910.43 | nM | Homo sapiens |
| Cmax | 4684.88 | nM | Homo sapiens |
| T1/2 | 1.6 | hr | Rattus norvegicus |
| T1/2 | 1.217 | hr | Homo sapiens |
| T1/2 | 6.223 | hr | Homo sapiens |
| T1/2 | 6.91 | hr | Homo sapiens |
| T1/2 | 1.217 | hr | Homo sapiens |
| T1/2 | 1.6 | hr | Rattus norvegicus |
| Tmax | 2.0 | hr | Homo sapiens |
| Tmax | 5.0 | hr | Homo sapiens |
| Vd | 1.6 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20660667 | 10.1128/aac.01455-09 | Human immunodeficiency virus 1 | 51 |
| 20660667 | 10.1128/aac.01455-09 | Unchecked | 30 |
| 20660667 | 10.1128/aac.01455-09 | Human immunodeficiency virus type 1 reverse transcriptase | 20 |
| 20160047 | 10.1128/aac.01110-09 | Homo sapiens | 16 |
| 19748778 | 10.1016/j.bmcl.2009.08.080 | Unchecked | 11 |
| 22071300 | 10.1016/j.bmcl.2011.10.027 | Human immunodeficiency virus | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 19748778 | 10.1016/j.bmcl.2009.08.080 | Rattus norvegicus | 3 |
| 20804202 | 10.1021/jm100762r | Rattus norvegicus | 2 |
| 19748778 | 10.1016/j.bmcl.2009.08.080 | Human immunodeficiency virus | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 22268494 | 10.1021/jm200990c | Human immunodeficiency virus 1 | 2 |
| 19748778 | 10.1016/j.bmcl.2009.08.080 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 19748778 | 10.1016/j.bmcl.2009.08.080 | Liver microsomes | 1 |
| 20804202 | 10.1021/jm100762r | Liver microsomes | 1 |
| 19748778 | 10.1016/j.bmcl.2009.08.080 | ADMET | 1 |
| 34003642 | 10.1021/acs.jmedchem.0c02245 | Cytochrome P450 3A | 1 |
| 20660667 | 10.1128/aac.01455-09 | Adrenergic receptor alpha-1 | 1 |
Data from ChEMBL 36 via Core Engine